|
End-of-day quote
Korea S.E.
2026-09-10
|
5-day change | 1st Jan Change | ||
| 11,020.00 KRW | -0.36% |
|
-3.25% | -14.24% |
| 02-09 | JW Lifescience Corporation announces Annual dividend, payable on April 24, 2026 | CI |
| 11-05 | JW Life Science Q3 operating profit 6.6 billion won, down 30% from year earlier | RE |
| Market Cap | 171B 126M 109M 103M 93.68M 175M 12.08B 177M 1.22B 471M 6.14B 475M 465M 19.58B | P/E 2024 |
3.83x | P/E 2025 | 6.96x |
|---|---|---|---|---|---|
| Enterprise Value | 211B 156M 134M 127M 116M 216M 14.92B 218M 1.51B 582M 7.59B 587M 574M 24.18B | EV / Sales 2024 |
1.03x | EV / Sales 2025 | 0.93x |
| Free-Float |
54.08% | Yield 2024 |
4.6% | Yield 2025 | - |
| 1 day | -0.36% | ||
| 1 week | -3.25% | ||
| Current month | -3.33% | ||
| 1 month | -4.26% | ||
| 3 months | -1.61% | ||
| 6 months | -11.77% | ||
| Current year | -14.24% |
| 1 week | 10,920 |  | 11,280 |
| 1 month | 10,920 | | 12,040 |
| Current year | 10,550 | | 14,000 |
| 1 year | 10,550 | | 15,580 |
| 3 years | 10,000 | | 15,580 |
| 5 years | 10,000 | | 18,200 |
| 10 years | 10,000 | | 34,450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung-Yeol Noh
CEO | Chief Executive Officer | 60 | 2024-02-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Eun-Kyung Ham
BRD | Director/Board Member | 63 | 2017-02-16 |
Jung-Yeol Noh
BRD | Director/Board Member | 60 | - |
Byeong-Suk Lee
BRD | Director/Board Member | 70 | 2022-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -3.25% | -7.16% | -22.28% | 128M | |
| -0.11% | -3.20% | +49.61% | +91.49% | 1,002B | |
| -0.27% | -3.22% | +50.51% | +65.89% | 644B | |
| +1.63% | -2.57% | +21.19% | +71.12% | 443B | |
| -0.63% | -1.06% | +28.11% | +34.59% | 343B | |
| +0.43% | -14.61% | +9.88% | +27.26% | 262B | |
| +0.93% | -1.82% | -1.82% | +8.41% | 245B | |
| -2.25% | -13.63% | +36.61% | +47.43% | 212B | |
| -0.90% | -5.09% | -15.47% | -57.75% | 199B | |
| -0.58% | -3.21% | +25.10% | +90.54% | 181B | |
| Average | -0.21% | -4.71% | +19.65% | +35.67% | 352.98B | |
| Weighted average by Cap. | -0.06% | -4.24% | +31.90% | +57.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 222B 165M 142M 134M 122M 228M 15.75B 230M 1.6B 614M 8.01B 620M 606M 25.53B | 258B 191M 164M 155M 142M 264M 18.25B 267M 1.85B 712M 9.28B 718M 703M 29.59B |
| Net income | 43.99B 32.59M 28.06M 26.48M 24.15M 45.09M 3.11B 45.53M 316M 121M 1.58B 123M 120M 5.05B | 28.61B 21.2M 18.25M 17.22M 15.7M 29.32M 2.03B 29.61M 205M 78.95M 1.03B 79.67M 77.95M 3.28B |
| Net Debt | 59.62B 44.18M 38.04M 35.89M 32.73M 61.11M 4.22B 61.7M 428M 165M 2.15B 166M 162M 6.84B | 40.08B 29.7M 25.57M 24.13M 22.01M 41.09M 2.84B 41.49M 288M 111M 1.44B 112M 109M 4.6B |
Employees
297
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | ₩11,020.00 | -0.36% | 19,112 |
| 26-09-09 | ₩11,060.00 | -0.09% | 6,354 |
| 26-09-08 | ₩11,070.00 | -0.36% | 9,707 |
| 26-09-07 | ₩11,110.00 | -1.33% | 14,215 |
| 26-09-04 | ₩11,260.00 | +0.54% | 9,477 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A234080 Stock
Select your edition
All financial news and data tailored to specific country editions
